GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China · Delayed Price · Currency is CNY 17.86
+0.12 (0.68%)
At close: Feb 3, 2026
SHA:600771 Revenue
GuangYuYuan Chinese Herbal Medicine had revenue of 281.44M CNY in the quarter ending September 30, 2025, with 20.31% growth. This brings the company's revenue in the last twelve months to 1.39B, up 15.04% year-over-year. In the year 2024, GuangYuYuan Chinese Herbal Medicine had annual revenue of 1.22B, down -4.87%.
Revenue (ttm)
1.39B
Revenue Growth
+15.04%
P/S Ratio
6.30
Revenue / Employee
800.36K
Employees
1,735
Market Cap
8.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | -62.59M | -4.87% |
| Dec 31, 2023 | 1.28B | 153.30M | 13.56% |
| Dec 31, 2022 | 1.13B | 276.50M | 32.37% |
| Dec 31, 2021 | 854.22M | -255.21M | -23.00% |
| Dec 31, 2020 | 1.11B | -107.67M | -8.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 829.92M |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |